Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
Sales | 5,076 | 9,780 | 6,570 | 2,429 | 1,316 |
Gross Profit | 5,076 | 9,780 | 6,570 | 2,429 | 1,316 |
Operating Expenses | 13,355 | 16,030 | 14,860 | 8,373 | 6,819 |
Operating Income | -8,279 | -6,250 | -8,290 | -5,944 | -5,503 |
Other Income | 1,582 | 2,147 | 2,370 | 1,729 | -1,357 |
Pre-tax Income | -6,697 | -4,103 | -5,920 | -4,215 | -6,860 |
Net Income Continuous | -6,697 | -4,103 | -5,920 | -4,215 | -6,860 |
Net Income | $-6,697 | $-4,103 | $-5,920 | $-4,215 | $-6,860 |
EPS Basic Total Ops | -1,012.10 | -440.04 | -880.09 | -638.06 | -1,474.15 |
EPS Basic Continuous Ops | -1,005.04 | -429.86 | -890.92 | -637.21 | -1,474.70 |
EPS Diluted Total Ops | -1,012.10 | -440.04 | -880.09 | -638.06 | -1,474.15 |
EPS Diluted Continuous Ops | -1,005.04 | -429.86 | -890.92 | -637.21 | -1,474.70 |
EBITDA(a) | $-8,235 | $-6,221 | $-8,262 | $-5,920 | $-5,484 |